HIV/AIDS: mRNA Vaccine Shows Promise in Pre-clinical Trial
Mar 3, 2022
HIV/AIDS: mRNA Vaccine Shows Promise in Pre-clinical Trial
Successful development of mRNA vaccines, BNT162b2 (of Pfizer/BioNTech) and mRNA-1273 (of Moderna) against the novel coronavirus SARS CoV-2 and the important role these vaccines played
#AIDS #HIV #HIVVaccine #mRNA #mRNAVaccine
SCIEU Team
